710 related articles for article (PubMed ID: 15258998)
21. Expression of hpttg proto-oncogene in lymphoid neoplasias.
Sáez C; Pereda T; Borrero JJ; Espina A; Romero F; Tortolero M; Pintor-Toro JA; Segura DI; Japón MA
Oncogene; 2002 Nov; 21(53):8173-7. PubMed ID: 12444553
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases.
Lai R; Medeiros LJ; Coupland R; McCourty A; Brynes RK
Mod Pathol; 1998 May; 11(5):457-63. PubMed ID: 9619599
[TBL] [Abstract][Full Text] [Related]
23. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.
Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668
[TBL] [Abstract][Full Text] [Related]
24. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
25. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
26. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
27. BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders.
Rodig SJ; Shahsafaei A; Li B; Mackay CR; Dorfman DM
Hum Pathol; 2005 Oct; 36(10):1113-9. PubMed ID: 16226112
[TBL] [Abstract][Full Text] [Related]
28. Expression of cyclin D2 and D3 in lymphoid lesions.
Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of heterogeneous nuclear ribonucleoprotein B1 in lymphoproliferative disorders: high expression in cells of follicular center origin.
Tani H; Ohshima K; Haraoka S; Hamasaki M; Kamma H; Ikeda S; Kikuchi M
Int J Oncol; 2002 Nov; 21(5):957-63. PubMed ID: 12370741
[TBL] [Abstract][Full Text] [Related]
30. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
[TBL] [Abstract][Full Text] [Related]
31. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
32. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
[TBL] [Abstract][Full Text] [Related]
33. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas.
Pittaluga S; Ayoubi TA; Wlodarska I; Stul M; Cassiman JJ; Mecucci C; Van Den Berghe H; Van De Ven WJ; De Wolf-Peeters C
J Pathol; 1996 Jun; 179(2):145-50. PubMed ID: 8758205
[TBL] [Abstract][Full Text] [Related]
34. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas.
Marmey B; Boix C; Barbaroux JB; Dieu-Nosjean MC; Diebold J; Audouin J; Fridman WH; Mueller CG; Molina TJ
Hum Pathol; 2006 Jan; 37(1):68-77. PubMed ID: 16360418
[TBL] [Abstract][Full Text] [Related]
35. The challenge of the microenvironment in B-cell lymphomas.
Coupland SE
Histopathology; 2011 Jan; 58(1):69-80. PubMed ID: 21261684
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Cdk9(55) and differential regulation of two Cdk9 isoforms.
Shore SM; Byers SA; Dent P; Price DH
Gene; 2005 Apr; 350(1):51-8. PubMed ID: 15780980
[TBL] [Abstract][Full Text] [Related]
37. Cyclin T1 but not cyclin T2a is induced by a post-transcriptional mechanism in PAMP-activated monocyte-derived macrophages.
Liou LY; Haaland RE; Herrmann CH; Rice AP
J Leukoc Biol; 2006 Feb; 79(2):388-96. PubMed ID: 16330531
[TBL] [Abstract][Full Text] [Related]
38. Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors.
De Falco G; Bellan C; D'Amuri A; Angeloni G; Leucci E; Giordano A; Leoncini L
Cancer Biol Ther; 2005 Mar; 4(3):277-81. PubMed ID: 15753651
[TBL] [Abstract][Full Text] [Related]
39. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
40. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.
Garcia JF; Roncador G; García JF; Sánz AI; Maestre L; Lucas E; Montes-Moreno S; Fernandez Victoria R; Martinez-Torrecuadrara JL; Marafioti T; Mason DY; Piris MA
Haematologica; 2006 Apr; 91(4):467-74. PubMed ID: 16585013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]